Design and Implementation of Broadband Hybrid 3-dB Couplers with Silicon-Based IPD Technology

por Xu, Mengmeng, Su, Jiangtao, Wang, Ruijin, Lin, Zhongjie, Xie, Weiyu, Liu, Jun
Publicado 2023

Clinicopathological features and survival for gallbladder NEN: a population-based study

por Cen, Dong, Liu, Hui, Wan, Zhe, Lin, Zhongjie, Wang, Yanting, Xu, Junjie, Liang, Yuelong
Publicado 2019

miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR

por Ji, Lin, Lin, Zhongjie, Wan, Zhe, Xia, Shunjie, Jiang, Shi, Cen, Dong, Cai, Liuxin, Xu, Junjie, Cai, Xiujun
Publicado 2020

TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib Resistance

por Xia, Shunjie, Ji, Lin, Tao, Liye, Pan, Yu, Lin, Zhongjie, Wan, Zhe, Pan, Haoqi, Zhao, Jie, Cai, Liuxin, Xu, Junjie, Cai, Xiujun
Publicado 2021

UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinoma

por Xu, Junjie, Ji, Lin, Ruan, Yeling, Wan, Zhe, Lin, Zhongjie, Xia, Shunjie, Tao, Liye, Zheng, Junhao, Cai, Liuxin, Wang, Yifan, Liang, Xiao, Cai, Xiujun
Publicado 2021

LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription

por Lin, Zhongjie, Xia, Shunjie, Liang, Yuelong, Ji, Lin, Pan, Yu, Jiang, Shi, Wan, Zhe, Tao, Liye, Chen, Jiang, Lin, Chengping, Liang, Xiao, Xu, Junjie, Cai, Xiujun
Publicado 2020

N(6)-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling

por Xu, Junjie, Wan, Zhe, Tang, Minyue, Lin, Zhongjie, Jiang, Shi, Ji, Lin, Gorshkov, Kirill, Mao, Qijiang, Xia, Shunjie, Cen, Dong, Zheng, Junhao, Liang, Xiao, Cai, Xiujun
Publicado 2020